Figure 3From: Effects of recombinant human growth hormone (rhGH) administration on body composition and cardiovascular risk factors in obese adolescent girlsChange in soluble intercellular adhesion molecule-1 (sICAM) levels in obese adolescent females. Change in sICAM levels in obese adolescent females after 6 months of recombinant human growth hormone therapy (rhGH +) (black bar) or placebo/no treatment (rhGH -) (gray bar).Back to article page